Biomarker Predictors for Immunotherapy Benefit in Breast: Beyond PD-L1
Sign Up to like & getrecommendations! Published in 2019 at "Current Breast Cancer Reports"
DOI: 10.1007/s12609-019-00331-5
Abstract: Immune checkpoint blockade (ICB) has changed the clinical course of multiple cancer types and durable responses have now been observed in breast cancer (BC) patients. Most data suggest that, compared to other subtypes, triple-negative BC… read more here.
Keywords: biomarker predictors; benefit breast; immunotherapy benefit; breast ... See more keywords